NAD+ Supplementation in 2026: What the Latest Research Says

On March 24, 2026, a landmark review paper was published in Nature Aging. More than 25 scientists from the University of Oslo, Akershus University Hospital, and research centers across Europe produced a comprehensive analysis of NAD+ metabolism and its role in aging, Alzheimer's disease, and Parkinson's disease.

This isn't a supplement company blog post. This is the scientific community putting its full collective weight behind NAD+ as a serious longevity intervention — and the findings are worth paying attention to.

Here's what the latest research actually says, what it means practically, and how to update your supplementation strategy in 2026.

What Is NAD+ and Why Does It Decline?

Nicotinamide adenine dinucleotide (NAD+) is a coenzyme found in every cell of your body. It's essential for energy metabolism, DNA repair, and regulation of cellular aging through proteins called sirtuins and PARP enzymes. Without adequate NAD+, mitochondria become dysfunctional, cells age faster, and DNA damage accumulates.

The problem? NAD+ levels decline dramatically with age. By the time most people reach their 50s and 60s, their cellular NAD+ levels are roughly half what they were at 20–30. This decline is now linked to a cascade of age-related conditions — metabolic dysfunction, neurodegeneration, cardiovascular disease, and impaired immune function.

NMN vs. NR: The 2026 Head-to-Head Results

For years, the longevity community debated whether NMN (nicotinamide mononucleotide) or NR (nicotinamide riboside) was the superior NAD+ precursor. In 2026, we finally have a direct head-to-head comparison.

In the Berven et al. study published in early 2026, researchers administered both compounds at equal doses (1.2g/day) and measured blood NAD+ response. The results were clear:

The practical implication: if you're paying for NMN, you may be getting less NAD+ boost per dollar. NR at equivalent doses outperforms. That said, both compounds raise NAD+ safely — the choice comes down to cost and availability.

What the Nature Aging 2026 Review Found

The March 2026 Nature Aging review is the most authoritative look at NAD+ to date. Here are the key conclusions from 25+ scientists:

• NAD+ decline is a driver, not just a marker, of aging. The review supports a causal role — depleted NAD+ doesn't just correlate with aging, it actively contributes to it.
• Neurodegeneration connection is real. NAD+ plays a direct role in protecting neurons from the kind of damage seen in Alzheimer's and Parkinson's. NAD+ augmentation may delay onset or slow progression.
• Sirtuin activation matters. NAD+ fuels sirtuins (SIRT1-7), the protein family responsible for DNA repair, inflammation control, and mitochondrial health. No NAD+, no sirtuin activity.
• NR and NMN are clinically safe. Across all human trials reviewed, no severe adverse events were reported. This is a significant safety signal for a class of supplements with widespread use.
• Metabolic improvements documented. Human studies show modest but real improvements in insulin sensitivity, energy metabolism, and physical performance.

Bryan Johnson's 2026 NAD+ Update

Bryan Johnson, who runs the most public and well-documented longevity protocol in the world, updated his stack in 2026. Two notable changes relevant to NAD+:

• Reduced NMN/NR from 7 to 6 days per week. Johnson appears to be experimenting with cycling — a small "off" day may prevent tolerance or allow the pathway to reset.
• Shifted to a more adaptive protocol. Rather than fixed doses, Johnson now adjusts based on real-time biomarker data, emphasizing that personalization outperforms standardized stacks.

The 6-days-on, 1-day-off approach is worth considering for long-term users. The science is thin on whether cycling is necessary, but it's a low-risk modification.

The Practical 2026 NAD+ Protocol

Based on the current evidence, here's what an evidence-based NAD+ supplementation protocol looks like in 2026:

Beyond Supplementation: What Else Raises NAD+

Supplements aren't the only way to support NAD+ levels. Several lifestyle interventions have strong evidence:

• Exercise (Zone 2 cardio): 150+ minutes per week of moderate cardio significantly raises NAD+ via AMPK activation and mitochondrial biogenesis.
• Fasting / time-restricted eating: 16:8 intermittent fasting activates SIRT1 and increases NAD+ through caloric restriction pathways.
• Heat exposure (sauna): Repeated sauna use activates heat shock proteins and supports mitochondrial NAD+ metabolism.
• Avoid NAD+ destroyers: Alcohol, chronic sleep deprivation, and ultra-processed food all deplete NAD+ faster.

The research increasingly suggests that lifestyle + supplements together outperform either alone. Exercise remains the most powerful single intervention for cellular energy metabolism.

Looking Ahead: What's Coming in NAD+ Research

The field is moving fast. In the next 12–18 months, watch for:

• Larger randomized controlled trials on NR/NMN with hard endpoints (not just biomarker changes)
• Alzheimer's prevention trial results using NAD+ augmentation as a primary or adjunct intervention
• Targeted NAD+ delivery to specific tissues (brain, muscle) via novel formulations
• Combination protocols — NAD+ precursors + senolytics + rapamycin tested together in human trials

Sources & Further Reading

• Nature Aging — NAD+ metabolism in aging, Alzheimer's, and Parkinson's (March 24, 2026) — University of Oslo et al.
• Berven et al. (2026) — NR vs. NMN head-to-head NAD+ bioavailability trial
• NMN clinical trial — 6-minute walk test, health score improvement vs placebo
• ITP March 2026 results — rapamycin.news / NIA Interventions Testing Program
• Bryan Johnson Blueprint 2026 update — mitohealth.com
• ScienceDaily — "Scientists say NAD+ could slow aging and fight Alzheimer's and Parkinson's" (March 2026)

This article is for informational purposes only. Consult a healthcare provider before starting any supplementation protocol.